13.63
Precedente Chiudi:
$13.66
Aprire:
$13.81
Volume 24 ore:
222.06K
Relative Volume:
0.79
Capitalizzazione di mercato:
$455.68M
Reddito:
-
Utile/perdita netta:
$-47.20M
Rapporto P/E:
-8.7108
EPS:
-1.5653
Flusso di cassa netto:
$-43.65M
1 W Prestazione:
+8.91%
1M Prestazione:
+13.62%
6M Prestazione:
-29.13%
1 anno Prestazione:
+0.00%
Mbx Biosciences Inc Stock (MBX) Company Profile
Nome
Mbx Biosciences Inc
Settore
Industria
Telefono
(317) 989-3100
Indirizzo
11711 N. MERIDIAN STREET, CARMEL
Confronta MBX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MBX
Mbx Biosciences Inc
|
13.63 | 418.47M | 0 | -47.20M | -43.65M | -1.5653 |
![]()
ONC
Beone Medicines Ltd Adr
|
258.27 | 26.01B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
445.85 | 114.30B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.3499 | 41.83M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
83.98 | 6.29B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
484.93 | 63.90B | 14.09B | 4.50B | 2.96B | 39.28 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-04-10 | Iniziato | Citizens JMP | Mkt Outperform |
2024-10-08 | Iniziato | Guggenheim | Buy |
2024-10-08 | Iniziato | JP Morgan | Overweight |
2024-10-08 | Iniziato | Jefferies | Buy |
2024-10-08 | Iniziato | Stifel | Buy |
Mbx Biosciences Inc Borsa (MBX) Ultime notizie
Deutsche Bank AG Buys New Position in MBX Biosciences, Inc. (NYSE:MBX) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases Shares of 6,335 MBX Biosciences, Inc. (NYSE:MBX) - Defense World
MBX Biosciences: Consider Peptide Developer With GLP Drugs As A Speculative Buy - Seeking Alpha
MBX Biosciences, Inc. (NYSE:MBX) Given Consensus Rating of “Buy” by Brokerages - Defense World
MBX Biosciences, Inc. (NYSE:MBX) Shares Sold by Millennium Management LLC - Defense World
Northern Trust Corp Invests $1.67 Million in MBX Biosciences, Inc. (NYSE:MBX) - Defense World
MBX Biosciences to Participate in June Investor Conferences - GlobeNewswire
MBX Biosciences Showcases Precision Peptide Pipeline at Two Major Healthcare Conferences This June - Stock Titan
Citadel Advisors LLC Grows Stock Holdings in MBX Biosciences, Inc. (NYSE:MBX) - Defense World
MBX Biosciences, Inc. (NYSE:MBX) Shares Acquired by The Manufacturers Life Insurance Company - Defense World
MBX Biosciences Reports Q1 2025 Financial Progress - TipRanks
MBX Biosciences, Inc.: Strong Buy Rating Amid Promising Phase II Data and Robust Financial Position - TipRanks
Stifel maintains MBX Biosciences stock Buy rating, $40 target By Investing.com - Investing.com Nigeria
Stifel maintains MBX Biosciences stock Buy rating, $40 target - Investing.com
MBX Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
MBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times
Wells Fargo & Company MN Purchases Shares of 5,844 MBX Biosciences, Inc. (NYSE:MBX) - Defense World
Hypoglycemia Market Poised for Notable Growth by 2032, Fueled - openPR.com
MBX Biosciences Up 28%, Insider Buyers Are Up 19% - simplywall.st
MBX Biosciences, Inc. (NYSE:MBX) Receives Consensus Rating of “Buy” from Analysts - Defense World
MBX Biosciences, Inc. (NYSE:MBX) Shares Purchased by Geode Capital Management LLC - Defense World
JMP maintains MBX Biosciences stock $38 target, upbeat on trial data - Investing.com Australia
Companies Like MBX Biosciences (NASDAQ:MBX) Are In A Position To Invest In Growth - Yahoo Finance
MBX Biosciences to Participate in Citizens and RBC May Investor Conferences - The Manila Times
MBX Biosciences Reveals Growth Strategy at Citizens and RBC Healthcare Conferences: Key Updates Coming - Stock Titan
5,593 Shares in MBX Biosciences, Inc. (NYSE:MBX) Acquired by Corebridge Financial Inc. - Defense World
25,000 Shares in MBX Biosciences, Inc. (NYSE:MBX) Acquired by Norges Bank - Defense World
MBX Biosciences, Inc. (NYSE:MBX) Receives $37.40 Consensus Price Target from Brokerages - Defense World
MBX Biosciences initiated at Market Outperform by Citizens - MSN
Director Makes Bold Move with Major MBX Biosciences Stock Purchase - TipRanks
JMP Securities Initiates Coverage of MBX Biosciences (MBX) with Market Outperform Recommendation - Nasdaq
MBX Biosciences: Innovative PEP Platform and Promising Pipeline Drive Buy Rating - TipRanks
MBX Bio stock initiated at Market Outperform by Citizens (MBX) - Seeking Alpha
MBX Biosciences director Pescovitz buys $45,311 in stock By Investing.com - Investing.com Canada
MBX Biosciences director Pescovitz buys $45,311 in stock - Investing.com
MBX Biosciences initiated with an Outperform at Citizens JMP - TipRanks
MBX Biosciences adds biotech veteran to board By Investing.com - Investing.com South Africa
MBX Biosciences adds biotech veteran to board - Investing.com Australia
MBX Biosciences Appoints Steve Hoerter to Board - TipRanks
MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors - GlobeNewswire
Charles Schwab Investment Management Inc. Invests $1.72 Million in MBX Biosciences, Inc. (NYSE:MBX) - Defense World
Bank of New York Mellon Corp Buys Shares of 23,914 MBX Biosciences, Inc. (NYSE:MBX) - Defense World
MBX Biosciences to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times
MBX Biosciences Unveils Next-Gen Peptide Therapies: CEO Presentation at Major Healthcare Conference - Stock Titan
MBX Biosciences Inc Reports Q4 2024 Net Loss of $15.6 Million, S - GuruFocus
Mbx Biosciences Inc Azioni (MBX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):